
AI in Healthcare: Investors’ Green and Red Flags Among Startups
During a panel discussion at the MedCity INVEST Digital Health conference, investors shared what they're looking for from AI startups and what their red flags are.
During a panel discussion at the MedCity INVEST Digital Health conference, investors shared what they're looking for from AI startups and what their red flags are.
This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did in the past couple years, according to Oak HC/FT Partner Billy Deitch. He noted that many startups have been preserving the capital over the past two years with the plan to raise funds in 2025.
It’s been a tumultuous past couple years for retail health companies —but there are still reasons to believe in the convenient model that retail health offers, said Annie Lamont, managing partner and co-founder of Oak HC/FT.
At HLTH 2024, I had dozens of conversations with providers, investors and digital health startup executives. Here are seven refreshingly honest takes I heard from them.
AxialHealthcare, a startup building software to manage opioid prescriptions and addiction, raised $15 million in funding. The company plans to use the new funds to build out tools to help addicted patients find help.
Komodo Health raised a $50 million funding round led by Andreessen Horowitz. The software company is building up a trove of healthcare data to drive better analytics.
The company, New York City-based Unite Us, raised the funding from investors including Oak HC/FT, Town Hall Ventures and Define Ventures.
Boston, Massachusetts-based WithMe Health launched out of stealth with $20 million in funding and Oak HC/FT Partner Chris Price at the helm.
The financing news comes on the heels of the company moving its headquarters to Atlanta from Plantation, Florida as a way to accommodate its rapid growth and tap into the technical and clinical talent in the region.
The company, Maven, raised funding from investors including Sequoia Capital, Oak HC/FT, 14W, Female Founders Fund and Spring Mountain Capital.
Oak HC/FT and F-Prime Capital Partners led the Series A round for the California startup, while Maverick Ventures and Greylock Partners participated.
The startup, which leverages technology to assist chronic kidney disease and end-stage renal disease patients, has wrapped up a $24 million Series A round led by Oak HC/FT.
The company's tool is meant to automate high-volume and repetitive tasks so that a healthcare organization's employees have more time to focus on other tasks that need human insight.
It is the second fund for Oak HC/FT which invests in growth stage companies in health IT and financial technology.
Investors from Safeguard Scientifics, Oak HC/FT, .406 Ventures and Comcast Ventures share their insights.